Breaking Medical News and In Depth Medical Stories

 
Search News:
     
PROGRAMS
 
 
Psoriasis drug may have potential in treating type 1 diabetes
Psoriasis drug may have potential in treating type 1 diabetes (September 25, 2013 - Insidermedicine) From Indiana - A new report published the Lancet Diabetes and Endocrinology finds that a psoriasis drug may have potential in treating type 1 diabetes. Researchers studied 49 newly diagnosed type 1 diabetics from 14 different clinical centres in the US. 33 of the participants received the psoriasis drug, Alefacept, every week for 12 weeks, followed by a break of 12 weeks, and then another 12 week session of injections. The 16 remaining participants received placebo with the same schedule. Researchers then measured how well participants pancreas could secrete insulin two hours after eating food. Results showed that those who received the diabetes drug had no increase in their insulin levels after eating, while those in the placebo group saw their levels increase.
 
OUR TEAM
More...  
EDITORIAL BOARD
More...